Last reviewed · How we verify
NCT03165461: IKING
Evaluation of the Use of Tracheal Intubation Through a Laryngeal Tube to Intubate Anesthetized Patients
trial in Airway Obstruction in 34 participants. Completed in 30 September 2017.
31 August 2017
Quick facts
| Lead sponsor | Formacion Internacional para la Docencia e Investigación de la Vía Aérea |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 34 |
| Start date | 26 May 2017 |
| Primary completion | 31 August 2017 |
| Estimated completion | 30 September 2017 |
| Sites | 1 location across Spain |
Conditions studied
- Airway Obstruction — all drugs for Airway Obstruction →
- Difficult Intubation — all drugs for Difficult Intubation →
Sponsor
Formacion Internacional para la Docencia e Investigación de la Vía Aérea
Who can join
18 and older, any sex, with Airway Obstruction or Difficult Intubation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Failed intubation is currently one of the most important factors leading to morbidity and mortality in anesthesia. The development of supraglottic airway devices (SGDs), such as the intubating laryngeal tube, has revolutionized airway management, as these devices allow adequate ventilation and oxygenation in situations where ventilation and/or intubation via conventional means pose a challenge. Several publications describe the usefulness of such devices for salvaging ventilation in patients that cannot be intubated with direct laryngoscopy or who cannot be ventilated with a facemask. In these salvage situations, SGDs are highly effective in achieving adequate patient oxygenation. Achieving effective oxygenation with an SGD and completely isolating the airway by intubation at the same time. This is now possible thanks to the so called supraglottic intubation devices (SGIDs). For that reason, we believe it is necessary to conduct a study that allows evaluation of the performance of this device in the context of daily clinical practice. Its design characteristics, its capacity to be used in intubation applications, its soft and atraumatic materials as well as its disposability augur this product a significant expansion in the next few years. Nonetheless, no data are available on the success of intubation when the intubating laryngeal tube suction device (ILTSD) is used. The idea behind this study is to assess the possibilities to use the ITLSD device to intubate patients in regular anesthetic practice.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03165461
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Airway Obstruction
Currently open trials in the same condition.
- NCT05974488 — The Efficacy of Distal Pharyngeal Airway for Oxygenation During TEE · NA · recruiting
- NCT03049202 — BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage Study · active not recruiting
Other Formacion Internacional para la Docencia e Investigación de la Vía Aérea trials
Trials by the same sponsor.
- NCT03208140 — A Study of Laryngoscopic Vision With the TotalTrack Device Versus Indirect Laryngoscopy · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03165461 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Formacion Internacional para la Docencia e Investigación de la Vía Aérea
- Last refreshed: 11 May 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03165461.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing